{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:02:19Z","timestamp":1793707339278,"version":"4.6.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacc.2025.12.027","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:15:42Z","timestamp":1768230942000},"page":"1094-1134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Cardiovascular Statistics in the United States, 2026"],"prefix":"10.1016","volume":"87","author":[{"given":"Rishi K.","family":"Wadhera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0674-2032","authenticated-orcid":false,"given":"Sanket S.","family":"Dhruva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnood","family":"Bikdeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-3584","authenticated-orcid":false,"given":"Marc P.","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis T.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5264-2169","authenticated-orcid":false,"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha J.","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2789-1758","authenticated-orcid":false,"given":"Mitsuaki","family":"Sawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Spatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Wasfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina M.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhaoNian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan M.","family":"Krumholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley H.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jacc.2025.12.027_bib1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023","volume":"86","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.jacc.2025.12.027_bib2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2025.12.027_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jama.2023.2307","article-title":"Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to March 2020","volume":"329","author":"Aggarwal","year":"2023","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jacc.2025.12.027_bib6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.7326\/M23-2109","article-title":"Cardiovascular health of middle-aged U.S. adults by income level, 1999 to March 2020: a serial cross-sectional study","volume":"176","author":"Liu","year":"2023","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jamacardio.2025.1536","article-title":"Hypertension, diabetes, and high cholesterol awareness among US adults","volume":"10","author":"Johnson","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.jacc.2025.12.027_bib8","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.121.17570","article-title":"Racial\/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013 to 2018","volume":"78","author":"Aggarwal","year":"2021","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jacc.2025.12.027_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamacardio.2025.0538","article-title":"Cardiovascular health among rural and urban US adults-healthcare, lifestyle, and social factors","volume":"10","author":"Liu","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"19","key":"10.1016\/j.jacc.2025.12.027_bib10","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.jacc.2025.12.027_bib11","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jacc.2025.12.027_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2025.12.027_bib13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","article-title":"Prevention and control of hypertension: JACC health promotion series","volume":"72","author":"Carey","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10022","key":"10.1016\/j.jacc.2025.12.027_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.jacc.2025.12.027_bib15","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2021.15187","article-title":"Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999-2018","volume":"326","author":"He","year":"2021","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jacc.2025.12.027_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024785","article-title":"County-level trends in hypertension-related cardiovascular disease mortality-United States, 2000 to 2019","volume":"11","author":"Vaughan","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.jacc.2025.12.027_bib17","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2021.01.032","article-title":"Rural-urban disparities: diabetes, hypertension, heart disease, and stroke mortality among Black and White adults, 1999-2018","volume":"77","author":"Aggarwal","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJMc1706292","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"377","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacc.2025.12.027_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"14","key":"10.1016\/j.jacc.2025.12.027_bib20","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.2024.28513","article-title":"Prevalence and Control of diabetes among US adults, 2013 to 2023","volume":"333","author":"Inoue","year":"2025","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"issue":"10193","key":"10.1016\/j.jacc.2025.12.027_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jacc.2025.12.027_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"10166","key":"10.1016\/j.jacc.2025.12.027_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jacc.2025.12.027_bib25","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jacc.2025.12.027_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023811","article-title":"National trends in use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists by cardiologists and other specialties, 2015 to 2020","volume":"11","author":"Adhikari","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.jacc.2025.12.027_bib27","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s11606-025-09380-2","article-title":"Prescription patterns for GLP-1 receptor agonists and SGLT2 inhibitors by physicians' years in practice","volume":"40","author":"Inoue","year":"2025","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.jacc.2025.12.027_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc21-1815","article-title":"Utilizationrates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs","volume":"45","author":"Mahtta","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jacc.2025.12.027_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/dc17-1414","article-title":"Long-term trends in antidiabetes drug usage in the U.S.: real-world evidence in patients newly diagnosed with type 2 diabetes","volume":"41","author":"Montvida","year":"2018","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jacc.2024.05.057","article-title":"Prescription patterns for sodium-glucose cotransporter 2 inhibitors in U.S. health systems","volume":"84","author":"Shin","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2025.12.027_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101882","article-title":"Type 2 diabetes mellitus-related mortality in the United States, 1999 to 2023","volume":"4","author":"Ahmed","year":"2025","journal-title":"JACC Adv"},{"issue":"21","key":"10.1016\/j.jacc.2025.12.027_bib33","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacc.2025.12.027_bib35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","article-title":"2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery","volume":"18","author":"Eisenberg","year":"2022","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"10.1016\/j.jacc.2025.12.027_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.soard.2019.12.022","article-title":"American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States","volume":"16","author":"English","year":"2020","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MLR.0000000000002113","article-title":"Trends in obesity care among US adults, 2010-2021","volume":"63","author":"Podolsky","year":"2025","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2025.12.027_bib38","author":"Montero"},{"issue":"9","key":"10.1016\/j.jacc.2025.12.027_bib39","article-title":"Trends and patterns in obesity-related deaths in the US (2010-2020): a comprehensive analysis using Centers for Disease Control and Prevention wide-ranging online data for epidemiologic research (CDC WONDER) data","volume":"16","author":"Achara","year":"2024","journal-title":"Cureus"},{"issue":"24","key":"10.1016\/j.jacc.2025.12.027_bib40","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jacc.2025.12.027_bib41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"24","key":"10.1016\/j.jacc.2025.12.027_bib42","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2022.12567","article-title":"Trends in lipid concentrations and lipid control among US adults, 2007-2018","volume":"328","author":"Aggarwal","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jacc.2025.12.027_bib44","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jamacardio.2023.3931","article-title":"Prevalence, awareness, and treatment of elevated LDL cholesterol in US adults, 1999-2020","volume":"8","author":"Sayed","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028205","article-title":"US trends in cholesterol screening, lipid levels, and lipid-lowering medication use in US adults, 1999 to 2018","volume":"12","author":"Gao","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.jacc.2025.12.027_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jamacardio.2023.0228","article-title":"Prevalence of statin use for primary prevention of atherosclerotic cardiovascular disease by race, ethnicity, and 10-year disease risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020","volume":"8","author":"Jacobs","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"14","key":"10.1016\/j.jacc.2025.12.027_bib47","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global Cardiovascular Risk Consortium. Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/tc-2022-057907","article-title":"Declines in cigarette smoking among US adolescents and young adults: indications of independence from e-cigarette vaping surge","volume":"34","author":"Pierce","year":"2025","journal-title":"Tob Control"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib49","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102645","article-title":"Trends and disparities in coronary artery disease prevalence among U.S. adults from 2019 to 2022","volume":"49","author":"Khalid","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2025.12.027_bib54","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.45964","article-title":"National trends in racial and ethnic disparities in use of recommended therapies in adults with atherosclerotic cardiovascular disease, 1999-2020","volume":"6","author":"Lu","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.jacc.2025.12.027_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101373","article-title":"Trends and disparities in CAD and AMI in the United States from 2000 to 2020","volume":"3","author":"Dimala","year":"2024","journal-title":"JACC Adv"},{"issue":"24","key":"10.1016\/j.jacc.2025.12.027_bib56","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/CIRCULATIONAHA.121.054378","article-title":"Racial and ethnic disparities in heart and cerebrovascular disease deaths during the COVID-19 pandemic in the United States","volume":"143","author":"Wadhera","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacc.2025.12.027_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2020.10.055","article-title":"Cardiovascular deaths during the COVID-19 pandemic in the United States","volume":"77","author":"Wadhera","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.12.027_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ahj.2021.09.009","article-title":"Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018","volume":"243","author":"Salah","year":"2022","journal-title":"Am Heart J"},{"issue":"15","key":"10.1016\/j.jacc.2025.12.027_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021061","article-title":"Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States","volume":"10","author":"Osman","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jacc.2021.10.045","article-title":"Rural-urban disparities in outcomes of myocardial infarction, heart failure, and stroke in the United States","volume":"79","author":"Loccoh","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacc.2025.12.027_bib61","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/archinternmed.2009.332","article-title":"Sex Differences in mortality after acute myocardial infarction: changes from 1994 to 2006","volume":"169","author":"Vaccarino","year":"2009","journal-title":"Arch Intern Med"},{"issue":"23","key":"10.1016\/j.jacc.2025.12.027_bib62","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/eurheartj\/ehad772","article-title":"Cardiovascular hospitalizations and mortality among adults aged 25\u201364 years in the USA","volume":"45","author":"Henry","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2025.12.027_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcin.2007.10.006","article-title":"A campaign to improve the timeliness of primary percutaneous coronary intervention: door-to-balloon: an alliance for quality","volume":"1","author":"Krumholz","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"issue":"22","key":"10.1016\/j.jacc.2025.12.027_bib64","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"85","author":"Rao","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacc.2025.12.027_bib68","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.106.174477","article-title":"Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention","volume":"113","author":"Jacobs","year":"2006","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacc.2025.12.027_bib69","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.jacc.2009.11.003","article-title":"National efforts to improve door-to-balloon time results from the door-to-balloon alliance","volume":"54","author":"Bradley","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib70","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.amjcard.2008.12.030","article-title":"Door-to-balloon times in hospitals within the Get-With The-Guidelines Registry after initiation of the Door-to-Balloon (D2B) Alliance","volume":"103","author":"Nallamothu","year":"2009","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2025.12.027_bib71","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jcin.2013.05.018","article-title":"Achieving sustainable first door-to-balloon times of 90 minutes for regional transfer ST-segment elevation myocardial infarction","volume":"6","author":"Wilson","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib72","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamacardio.2025.1411","article-title":"Institutional variability in processes of care and outcomes among patients with STEMI in the US","volume":"10","author":"Sammour","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004983","article-title":"Trends in performance and opportunities for improvement on a composite measure of acute myocardial infarction care","volume":"12","author":"Desai","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102010","article-title":"CDC WONDER: Trends in acute myocardial infarction mortality in the United States From 1968 to 2021","volume":"4","author":"Waqas","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacc.2025.12.027_bib75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s44325-025-00046-w","article-title":"Demographic and regional trends of acute myocardial infarction-related mortality among young adults in the US, 1999\u20132020","volume":"2","author":"Li","year":"2025","journal-title":"npj Cardiovasc Health"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib76","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1938","article-title":"Twenty-Year trends in outcomes for older adults with acute myocardial infarction in the United States","volume":"2","author":"Krumholz","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jacc.2025.12.027_bib77","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008112","article-title":"Ten-year trends in patient characteristics, treatments, and outcomes in myocardial infarction from National Cardiovascular Data Registry Chest Pain-MI Registry","volume":"15","author":"Gandhi","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.jacc.2025.12.027_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.jacc.2025.12.027_bib79","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/jamacardio.2020.3654","article-title":"Trends in the prevalence of self-reported heart failure by race\/ethnicity and age from 2001 to 2016","volume":"5","author":"Rethy","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2025.12.027_bib80","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamacardio.2018.0385","article-title":"Global Burden of Cardiovascular Diseases Collaboration. The burden of cardiovascular diseases among US states, 1990-2016","volume":"3","author":"Roth","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2025.12.027_bib81","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacc.2025.12.027_bib82","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","article-title":"Titration of medical therapy for heart failure with reduced ejection fraction","volume":"73","author":"Greene","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2025.12.027_bib83","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jchf.2024.03.001","article-title":"Eligibility and projected benefits of rapid initiation of quadruple therapy for newly diagnosed heart failure","volume":"12","author":"Greene","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"7","key":"10.1016\/j.jacc.2025.12.027_bib84","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamacardio.2023.1266","article-title":"Contemporary use of sodium-glucose cotransporter-2 inhibitor therapy among patients hospitalized for heart failure with reduced ejection fraction in the US: The Get With The Guidelines-Heart Failure Registry","volume":"8","author":"Pierce","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib85","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jama.2017.8444","article-title":"Association of changing hospital readmission rates with mortality rates after hospital discharge","volume":"318","author":"Dharmarajan","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jacc.2025.12.027_bib86","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.2777","article-title":"Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction, heart failure, and pneumonia","volume":"1","author":"Khera","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"24","key":"10.1016\/j.jacc.2025.12.027_bib87","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1056\/NEJMsa1613412","article-title":"Changes in hospital quality associated with hospital value-based purchasing","volume":"376","author":"Ryan","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jacc.2025.12.027_bib88","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010149","article-title":"Policy strategies to advance cardiovascular health in the United States-building on a century of progress","volume":"17","author":"Wadhera","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.12.027_bib89","article-title":"Hospital revisits within 30 days after discharge for medical conditions targeted by the hospital readmissions reduction program in the United States: national retrospective analysis","volume":"366","author":"Wadhera","year":"2019","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.jacc.2025.12.027_bib90","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMp1901225","article-title":"The hospital readmissions reduction program - time for a reboot","volume":"380","author":"Wadhera","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jacc.2025.12.027_bib91","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamacardio.2024.0615","article-title":"Reversals in the decline of heart failure mortality in the US, 1999 to 2021","volume":"9","author":"Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"25","key":"10.1016\/j.jacc.2025.12.027_bib92","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2025.05.018","article-title":"JACC data report: cardiovascular disease mortality trends in the United States (1999-2023)","volume":"85","author":"Yan","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.12.027_bib93","article-title":"HF STATS 2025: heart failure epidemiology and outcomes statistics an updated 2025 report from the Heart Failure Society of America","year":"2025","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.jacc.2025.12.027_bib94","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jchf.2024.08.016","article-title":"National trends in heart failure hospitalizations and readmissions from 2010 to 2021","volume":"13","author":"Agarwal","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"20","key":"10.1016\/j.jacc.2025.12.027_bib95","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2025.12.027_bib96","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/ejhf.3003","article-title":"Sex differences in long-term outcomes following acute heart failure hospitalization: findings from the Get With The Guidelines-Heart Failure Registry","volume":"25","author":"Keshvani","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.jacc.2025.12.027_bib97","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jacc.2008.09.063","article-title":"Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study)","volume":"53","author":"McDermott","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2025.12.027_bib98","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2025.12.027_bib99","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"Allison","year":"2007","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.jacc.2025.12.027_bib100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003796","article-title":"Peripheral artery disease prevalence and incidence estimated from both outpatient and inpatient settings among Medicare fee-for-service beneficiaries in the Atherosclerosis Risk in Communities (ARIC) Study","volume":"6","author":"Kalbaugh","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"24","key":"10.1016\/j.jacc.2025.12.027_bib101","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Writing Committee Members","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib102","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcin.2022.09.022","article-title":"Guideline-directed medical therapy and long-term mortality and amputation outcomes in patients undergoing peripheral vascular interventions","volume":"16","author":"Smolderen","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.jacc.2025.12.027_bib103","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jvs.2023.04.025","article-title":"Optimal medical management in patients undergoing peripheral vascular interventions for chronic limb-threatening ischemia is associated with improved outcomes","volume":"78","author":"Chang","year":"2023","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.jacc.2025.12.027_bib104","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc18-1380","article-title":"Resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult U.S. population","volume":"42","author":"Geiss","year":"2019","journal-title":"Diabetes Care"},{"issue":"16","key":"10.1016\/j.jacc.2025.12.027_bib105","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2016.02.040","article-title":"Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011","volume":"67","author":"Agarwal","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2025.12.027_bib106","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009459","article-title":"Sex differences in management and outcomes of critical limb ischemia in the Medicare population","volume":"13","author":"Mentias","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.jacc.2025.12.027_bib107","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007425","article-title":"Race and socioeconomic status independently affect risk of major amputation in peripheral artery disease","volume":"7","author":"Arya","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jacc.2025.12.027_bib108","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jvs.2021.08.096","article-title":"Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial","volume":"75","author":"Govsyeyev","year":"2022","journal-title":"J Vasc Surg"},{"issue":"20","key":"10.1016\/j.jacc.2025.12.027_bib111","doi-asserted-by":"crossref","first-page":"449","DOI":"10.15585\/mmwr.mm7320a1","article-title":"Prevalence of stroke - behavioral risk factor surveillance system, United States, 2011-2022","volume":"73","author":"Imoisili","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.jacc.2025.12.027_bib112","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1161\/STROKEAHA.124.048174","article-title":"Twenty years of sustained improvement in quality of care and outcomes for patients hospitalized with stroke or transient ischemic attack: data from the Get With The Guidelines-Stroke Program","volume":"55","author":"Xian","year":"2024","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jacc.2025.12.027_bib113","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1161\/STROKEAHA.124.050446","article-title":"National versus state-level racial disparities in acute stroke interventions using Get With The Guidelines-Stroke data","volume":"56","author":"Kim","year":"2025","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jacc.2025.12.027_bib114","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1161\/STROKEAHA.124.046527","article-title":"Twenty years of Get With The Guidelines-Stroke: celebrating past successes, lessons learned, and future challenges","volume":"55","author":"Reeves","year":"2024","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jacc.2025.12.027_bib116","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/ije\/dyac210","article-title":"Epidemiology and trends in stroke mortality in the USA, 1975-2019","volume":"52","author":"Ananth","year":"2023","journal-title":"Int J Epidemiol"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725105585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725105585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:07:32Z","timestamp":1784938052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725105585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":103,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0735109725105585"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.12.027","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Statistics in the United States, 2026","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}